Washington Trust Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Sell |
17,034
-139
| -0.8% | -$25.8K | 0.26% | 60 |
|
|
2025
Q1 | $3.6M | Buy |
17,173
+6
| +0% | +$1.26K | 0.32% | 57 |
|
|
2024
Q4 | $3.05M | Buy |
17,167
+170
| +1% | +$30.2K | 0.26% | 63 |
|
|
2024
Q3 | $3.36M | Buy |
16,997
+673
| +4% | +$133K | 0.29% | 60 |
|
|
2024
Q2 | $2.8M | Sell |
16,324
-636
| -4% | -$109K | 0.26% | 62 |
|
|
2024
Q1 | $3.09M | Sell |
16,960
-16
| -0.1% | -$2.91K | 0.28% | 61 |
|
|
2023
Q4 | $2.63M | Buy |
16,976
+203
| +1% | +$31.5K | 0.25% | 62 |
|
|
2023
Q3 | $2.5M | Buy |
16,773
+18
| +0.1% | +$2.68K | 0.26% | 66 |
|
|
2023
Q2 | $2.26M | Sell |
16,755
-397
| -2% | -$53.5K | 0.22% | 67 |
|
|
2023
Q1 | $2.73M | Buy |
17,152
+107
| +0.6% | +$17.1K | 0.28% | 63 |
|
|
2022
Q4 | $2.75M | Sell |
17,045
-479
| -3% | -$77.4K | 0.3% | 63 |
|
|
2022
Q3 | $2.35M | Buy |
17,524
+136
| +0.8% | +$18.3K | 0.22% | 78 |
|
|
2022
Q2 | $2.66M | Sell |
17,388
-410
| -2% | -$62.8K | 0.23% | 74 |
|
|
2022
Q1 | $2.89M | Sell |
17,798
-230
| -1% | -$37.3K | 0.2% | 78 |
|
|
2021
Q4 | $2.44M | Buy |
+18,028
| New | +$2.44M | 0.17% | 84 |
|